TABLE 2.
Basal value for counterregulatory hormones at the start of day 2 exercise after two 120-min euglycemic clamps (anteEugly), hypoglycemic clamps (anteHypo), or euglycemic clamps with intravenous cortisol infusions of 1 μg · kg−1 · min−1 (anteCort) or 2 μg · kg−1 · min−1 (anteCort2) on day 1
| anteEugly | anteHypo | anteCort1 | anteCort2 | |
|---|---|---|---|---|
| Epinephrine (pmol/l) | 279 ± 55 | 225 ± 38 | 290 ± 55 | 230 ± 33 |
| Norepinephrine (nmol/l) | 1.6 ± 0.2 | 1.4 ± 0.2 | 1.3 ± 0.2 | 1.2 ± 0.1 |
| Pancreatic polypeptide (pmol/l) | 16 ± 3 | 19 ± 6 | 21 ± 6 | 20 ± 4 |
| Glucagon (ng/l) | 44 ± 3 | 45 ± 4 | 54 ± 10 | 43 ± 3 |
| Growth hormone (μg/l) | 4 ± 3 | 4 ± 2 | 2 ± 1 | 2 ± 1 |
| Cortisol (nmol/l) | 359 ± 55 | 367 ± 47 | 286 ± 62 | 442 ± 59 |
Data are means ± SEM. n = 22 type 1 diabetic subjects (11 men/11 women).